Related Experiment Video
Updated: Jul 23, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Why do older adults decline participation in research? Results from two deprescribing clinical trials
Thomas E Strayer1,2, Emily K Hollingsworth3,4, Avantika S Shah3,5
1Center for Quality Aging, Vanderbilt University Medical Center, 2147 Belcourt Ave., Nashville, TN, 37212, USA. thomas.e.strayer@vumc.org.
Background:
Heterogenous older adult populations are underrepresented in clinical trials, and their participation is necessary for interventions that directly target them. The purpose of this study was to evaluate reasons why hospitalized older adults declined participation in two deprescribing clinical trials.
Methods:
We report enrollment data from two deprescribing trials, Shed-MEDS (non-Veterans) and VA DROP (Veterans). For both trials, inclusion criteria required participants to be hospitalized, age 50 or older, English-speaking, and taking five or more home medications. Eligible patients were approached for enrollment while hospitalized. When an eligible patient or surrogate declined participation, the reason(s) were recorded and subsequently analyzed inductively to develop themes, and a chi-square test was used for comparison (of themes between Veterans and non-Veterans).
Results:
Across both trials, 1226 patients (545 non-Veterans and 681 Veterans) declined enrollment and provided reasons, which were condensed into three themes: (1) feeling overwhelmed by their current health status, (2) lack of interest or mistrust of research, and (3) hesitancy to participate in a deprescribing study. A greater proportion of Veterans expressed a lack of interest or mistrust in research (42% vs 26%, chi-square value = 36.72, p < .001), whereas a greater proportion of non-Veterans expressed feeling overwhelmed by their current health status (54% vs 35%, chi-square value = 42.8 p < 0.001). Across both trials, similar proportion of patients expressed hesitancy to participate in a deprescribing study, with no significant difference between Veterans and non-Veterans (23% and 21%).
Conclusions:
Understanding the reasons older adults decline participation can inform future strategies to engage this multimorbid population.
Insights
Older adults often decline deprescribing trials due to feeling overwhelmed, mistrust in research, or hesitancy about deprescribing. Understanding these barriers is key to improving clinical trial diversity in older populations.
Area of Science:
- Gerontology
- Clinical Trials
- Pharmacology
Background:
- Older adults are underrepresented in clinical trials.
- Their participation is crucial for developing targeted interventions.
- Hospitalized older adults' reasons for declining deprescribing trials were evaluated.
Purpose of the Study:
- To identify and analyze the reasons why hospitalized older adults declined participation in two deprescribing clinical trials.
- To understand barriers to research participation in this demographic.
Main Methods:
- Enrollment data from two deprescribing trials (Shed-MEDS and VA DROP) were analyzed.
- Inclusion criteria: hospitalized, age 50+, English-speaking, 5+ home medications.
- Reasons for declining were inductively themed and compared between Veterans and non-Veterans using chi-square tests.
Main Results:
- 1226 patients declined enrollment, providing reasons condensed into three themes: feeling overwhelmed, lack of interest/mistrust in research, and deprescribing hesitancy.
- Veterans were more likely to express mistrust (42% vs 26%), while non-Veterans were more likely to feel overwhelmed (54% vs 35%).
- Hesitancy towards deprescribing showed no significant difference between groups (23% vs 21%).
Conclusions:
- Key barriers to trial participation for older adults include health status, research mistrust, and deprescribing concerns.
- Findings can inform strategies to enhance engagement of multimorbid older adults in clinical research.
- Addressing these specific reasons may improve recruitment and trial diversity.
More Related Videos
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Longitudinal Research
Ethics in Research
Factors Affecting Drug Response: Overview
Desensitization and Tachyphylaxis
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Clinical Trials
There are four phases in a clinical trial. A phase one...